On September 16, the selection results of the 4th China Quality Award were officially announced at the China Quality (Hangzhou) Conference. KingMed, BGI and Wego were awarded the nomination award of the 4th China Quality Award.

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a merger with Artisan Acquisition, a special purpose acquisition company. According to the Wall Street Journal, the deal values the company at $1.25 billion.

Thermo Fisher Scientific said on Thursday that it has received CE-IVD marking for its TaqPath COVID-19 RNase P 2.0 kit, which has been designed to provide accurate results by compensating for current and future COVID-19 viral mutations.

Biotech companies Abacus Diagnostica, Kaivogen, and Labrox announced Tuesday that they are combining to create an in vitro diagnostics firm to develop near-patient antibody and PCR tests for infectious diseases and cancers that could be run from a single device.

Mesa Laboratories said on Tuesday that it has acquired mass spectrometry-based genetic analysis firm Agena Bioscience for $300 million in cash.

On September 16, Beijing Hotgen Biotech Co.,Ltd. stated that the company proposed to establish Beijing Yaojing Gene Technology Co., Ltd. with a joint investment of CNY100 million with Mr. LIN Changqing (Chairman of Hotgen) and Beijing Yaojing Enterprise Management Center.

Ginkgo Bioworks said on Tuesday that it has completed its merger with special purpose acquisition company Soaring Eagle Acquisition and that its stock will start to trade publicly on the New York Stock Exchange on Friday.

Cepheid announced on Tuesday that it has received Emergency Use Authorization from the US Food and Drug Administration for a new version of its multiplex SARS-CoV-2, influenza, and respiratory syncytial virus test.

Gator Bio, Inc. announced today the launch of the GatorPlus, a next generation biolayer interferometry (BLI) instrument and two new biosensor products, Gator™ Flex SA Kit and Gator™ AAVX probe.

Beckman Coulter continues to pay attention to the development of the coagulation market, and recently launched a strategic cooperation with Accurdx in the field of intelligent coagulation, setting another milestone in localization innovation.

Dublin-based diagnostics firm Trinity Biotech on Thursday reported a 61 percent year-over-year increase in second quarter revenues, driven in part by sales of its PCR viral transport media for SARS-CoV-2 testing.

The Japan Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory agency, has granted approval to the Thermo Fisher Scientific's Oncomine Dx Target Test to be used as a companion diagnostic to identify patients with RET-fusion positive non-small cell lung cancer (NSCLC).

On September 13, 2021, Shanghai Labway Medical Laboratory Co., Ltd. was listed on Shenzhen Stock Exchange (SZSE) ChiNext. Stock code: 688622. The number of new shares publicly issued this time is 48.062 million shares, the issue price is CNY4.17/share, and the opening price is CNY18.25/share.

On September 13, 2021, Guangzhou Hexin Instrument Co., Ltd. (hereinafter referred to as " Hexin") was listed on SSE STAR Market. Stock code: 688622. The number of A shares publicly issued this time is 17.5 million shares, the issue price is CNY 17.7/share, and the opening price is CNY 92.11 /share.

Life science company RareCyte said on Thursday that it completed $24 million in financing from both new and existing investors.